Invention Grant
US06685942B1 Human neutralizing monoclonal antibodies to respiratory syncytial virus 失效
人中和呼吸道合胞病毒的单克隆抗体

Human neutralizing monoclonal antibodies to respiratory syncytial virus
Abstract:
A method for providing passive immmunotherapy to respiratory syncytial virus (RSV) disease in a host is disclosed. The method includes administering to a host a human monoclonal antibody Fab fragment that neutralizes both antigenic subgroup A and subgroup B of respiratory syncytial virus (RSV), or a monoclonal antibody comprising the fragment.
Information query
Patent Agency Ranking
0/0